| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Regular Articles |
From the Division of Fetal Medicine*
and
Reproductive Physiopathology Group,
Academic
Department of Obstetrics and Gynaecology, and the Department of
Biochemistry,
University of Birmingham,
Birmingham, United Kingdom
Severe intrauterine growth restriction (IUGR) is characterized by abnormal placentation. Mouse gene knockout studies show that an absence of either hepatocyte growth factor (HGF) or its receptor, c-met, leads to intrauterine death secondary to severe IUGR with deficient placentation. In this study, immunocytochemistry localized HGF protein throughout placental villi across gestation, whereas c-met protein was localized only to the perivillous trophoblast and vascular endothelium. Within the IUGR placentae, a reduction in HGF immunostaining within the villous stroma was observed. HGF mRNA was strongly expressed in the perivascular tissue around the stem villous arteries throughout gestation, with weaker expression within the villous stroma and the terminal villi. c-met mRNA expression was limited to the perivillous trophoblast, particularly in the first trimester, with only a faint hybridization signal from the villous stroma. Placental mRNA expression was examined quantitatively using a ribonuclease protection assay: HGF and c-met mRNA expression increased from the first to the second trimester, reaching a zenith before decreasing again through the third trimester to term. HGF mRNA levels were significantly reduced in the IUGR placentae (P = 0.036), whereas c-met mRNA expression was within the normal range for gestation. These findings suggest that HGF derived from the perivascular tissue of stem villous arteries may play an important role in controlling normal villous development. Whereas reduced expression of HGF within IUGR placentae does not prove a causative link with abnormal villous development, the association lends support to this possibility.
This article has been cited by other articles:
 |
|
 |
|
  M. Mori, G. Ishikawa, S.-S. Luo, T. Mishima, T. Goto, J. M. Robinson, S. Matsubara, T. Takeshita, H. Kataoka, and T. Takizawa The Cytotrophoblast Layer of Human Chorionic Villi Becomes Thinner but Maintains Its Structural Integrity During Gestation Biol Reprod, January 1, 2007; 76(1): 164 - 172. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J.-T. Chen, T.-S. Lin, K.-C. Chow, H.-H. Huang, S.-H. Chiou, S.-F. Chiang, H.-C. Chen, T.-L. Chuang, T.-Y. Lin, and C.-Y. Chen Cigarette Smoking Induces Overexpression of Hepatocyte Growth Factor in Type II Pneumocytes and Lung Cancer Cells Am. J. Respir. Cell Mol. Biol., March 1, 2006; 34(3): 264 - 273. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. Murthi, V. Doherty, J. Said, S. Donath, S. P. Brennecke, and B. Kalionis Homeobox Gene HLX1Expression Is Decreased in Idiopathic Human Fetal Growth Restriction Am. J. Pathol., February 1, 2006; 168(2): 511 - 518. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Zehnder, K. N. Evans, M. D. Kilby, J. N. Bulmer, B. A. Innes, P. M. Stewart, and M. Hewison The Ontogeny of 25-Hydroxyvitamin D3 1{alpha}-Hydroxylase Expression in Human Placenta and Decidua Am. J. Pathol., July 1, 2002; 161(1): 105 - 114. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
A. Dokras, L. M.G. Gardner, E. A. Seftor, and M. J.C. Hendrix Regulation of Human Cytotrophoblast Morphogenesis by Hepatocyte Growth Factor/Scatter Factor Biol Reprod, October 1, 2001; 65(4): 1278 - 1288. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. A. Somerset, E. Jauniaux, A. J. Strain, S. Afford, and M. D. Kilby Hepatocyte Growth Factor Concentration in Maternal and Umbilical Cord Blood Samples and Expression in Fetal Liver Reproductive Sciences, November 1, 2000; 7(6): 333 - 337. [Abstract] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
